老年严重肢体缺血患者腔内、外科或保守治疗后的生活质量与死亡率
研究前瞻性纳入2012年1月至2016年2月共195例≥70岁严重肢体缺血患者,分为腔内、外科和保守治疗组,按70-79岁和>80岁两个年龄段分析,随访至6个月。主要终点为生活质量,次要终点为死亡率和保肢率。结果显示70-79岁外科治疗者6个月死亡率显著低于腔内和保守治疗,>80岁各组死亡率无显著差异;外科治疗70-79岁患者各随访点生活质量均显著提高,保守治疗组该年龄段未改善,而>80岁所有组包括保守治疗组6个月生活质量均显著改善。
要点
- 70-79岁外科治疗者6个月死亡率为4%,显著低于腔内治疗24%和保守治疗25%。
- >80岁患者6个月死亡率在腔内38%、外科15%和保守27%间无显著差异。
- 保守治疗组70-79岁生活质量未改善,但>80岁所有组6个月生活质量均显著改善。
核心结论
- 被判定适合手术的老年患者可能从外科血运重建中获益最大,表现为低死亡率、低不良事件和多个领域生活质量的显著改善。
- 所有三种治疗方式在6个月时均显著提高了身体健康。
- 对于不适合血运重建的患者,保守治疗似乎是可接受的治疗选择,6个月时身体健康有所改善。
研究设计与样本
- 前瞻性纳入2012年1月至2016年2月共195例≥70岁严重肢体缺血患者,分为6组(腔内血运重建、外科血运重建和保守治疗),并按70-79岁和>80岁两个年龄段分析。
- 随访时间为5-7天、6周和6个月,使用世界卫生组织生活质量-BREF问卷评估生活质量,并记录血管-生理和手术严重度评分以枚举死亡率和并发症。
- 主要终点为生活质量,次要终点为死亡率和保肢率。
主要发现
- 70-79岁外科治疗患者6个月死亡率为4%,显著低于腔内治疗24%(P=0.001)和保守治疗25%(P=0.02)。
- >80岁患者6个月死亡率在腔内治疗38%、外科治疗15%和保守治疗27%之间无显著差异。
- 70-79岁外科治疗患者在所有随访时间点生活质量均显著提高,腔内治疗患者在6个月时生活质量显著提高,保守治疗组该年龄段生活质量未改善。
- >80岁所有患者包括保守治疗组在6个月时生活质量结果均显著改善。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Revascularization to relieve ischemic pain and prevent limb loss is the cornerstone of critical limb ischemia (CLI) treatment; however, not all elderly patients are deemed fit for revascularization. Patient-related outcome measurements are important in these patients. Quality of life (QoL) results regarding the effect of endovascular, surgical, and conservative treatment on the QoL in the elderly are scarce in the current literature. The goal of this study was to explore the outcomes of the different treatment modalities in elderly patients suffering from CLI, with a specific focus on QoL. METHODS: A total of 195 CLI patients ≥70 years were prospectively included between January 2012 and February 2016 and divided into 6 groups (endovascular revascularization, surgical revascularization, and conservative treatment). Two age groups (70-79 and >80 years) were analyzed. Follow-up was performed at 5-7 days, 6 weeks, and 6 months. World Health Organization Quality of Life-BREF questionnaire was used to determine QoL. The Vascular-Physiological and Operative Severity Score for Enumeration of Mortality and Morbidity score was noted. QoL was used as the primary end point, with mortality and limb salvage as the secondary end points. RESULTS: Six-month mortality was significantly lower in surgically treated patients aged 70-79 years (4%) as compared with endovascular (24%, P = 0.001) or conservative treatment (25%, P = 0.02). There was no significant difference in 6-month mortality in patients >80 years among endovascularly (38%), surgically (15%), and conservatively treated patients (27%). QoL significantly increased at all follow-up moments in surgically treated patients between 70 and 79 years and at 6 months in endovascularly treated patients. Conservatively treated patients did not improve their QoL in this age group. All patients aged >80 years, including conservatively treated patients, showed significantly improved QoL results at 6 months. CONCLUSIONS: Elderly patients judged fit for surgery may benefit the most from surgical revascularization, reporting low mortality rates, low adverse events and significantly gained QoL in multiple domains. However, all 3 treatment modalities have significantly increased physical health at 6 months. Conservative therapy seems to be an acceptable treatment option in patients unfit for revascularization with gained physical health at 6 months.
引用
- Steunenberg SL, de Vries J, Raats JW, et al. Quality of Life and Mortality after Endovascular, Surgical, or Conservative Treatment of Elderly Patients Suffering from Critical Limb Ischemia. Ann Vasc Surg. 2018. PMID: 29772334. doi:10.1016/j.avsg.2018.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。